| abstract |
The present invention provides compounds of formula (I) that are useful as inhibitors of protein kinases. Of the compound. The present invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of various diseases, conditions, or disorders, particularly cancer. The compounds of the invention and their pharmaceutically acceptable compositions are CDK-2, cMET, FLT-3, JAK-3, GSK-3, IRAK-4, SYK, p70S6K, TAK-1, and ZAP-70. It has now been found to be effective as an inhibitor of protein kinases. |